Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
11.00
-0.01 (-0.09%)
Feb 20, 2026, 4:00 PM EST - Market closed
Fortrea Holdings Revenue
Fortrea Holdings had revenue of $701.30M in the quarter ending September 30, 2025, with 3.91% growth. This brings the company's revenue in the last twelve months to $2.76B, up 1.88% year-over-year. In the year 2024, Fortrea Holdings had annual revenue of $2.70B, down -5.14%.
Revenue (ttm)
$2.76B
Revenue Growth
+1.88%
P/S Ratio
0.37
Revenue / Employee
$190,338
Employees
14,500
Market Cap
1.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.70B | -146.10M | -5.14% |
| Dec 31, 2023 | 2.84B | 5.50M | 0.19% |
| Dec 31, 2022 | 2.84B | -220.50M | -7.21% |
| Dec 31, 2021 | 3.06B | 477.20M | 18.49% |
| Dec 31, 2020 | 2.58B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Valneva SE | 211.09M |
| ARS Pharmaceuticals | 142.77M |
| UroGen Pharma | 96.52M |
| Theravance Biopharma | 80.33M |
| AbCellera Biologics | 35.33M |
| Aktis Oncology | 5.56M |
FTRE News
- 5 days ago - Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services - GlobeNewsWire
- 24 days ago - Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call - GlobeNewsWire
- 4 weeks ago - Fortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE - PRNewsWire
- 5 weeks ago - Fortrea Holdings Inc. (FTRE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery - GlobeNewsWire